Paper Details

  1. Home
  2. Paper Details

Effects of fluoxetine versus bright light in the treatment of seasonal affective disorder.

Author: HawellekB, HöflichG, KasperS, MartinezB, MöllerH J, NickelsenT, RuhrmannS

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Overview

This randomized, parallel design study found that both bright light and fluoxetine produced a good antidepressant effect in patients with seasonal affective disorder (SAD), with an apparently better response to bright light that requires confirmation in a larger sample.
Paper Details　
Original Abstract of the Article :
BACKGROUND: Disturbances of serotonergic neurotransmission appear to be particularly important for the pathophysiology of winter depression. This study investigated whether fluoxetine has antidepressant effects comparable to bright light in the treatment of seasonal affective disorder (winter type)....See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1017/s0033291798006813

データ提供：米国国立医学図書館（NLM）

Shining Light on Seasonal Blues: A Battle Between Fluoxetine and Bright Light

The realm of [mental health] presents a fascinating landscape, and [seasonal affective disorder (SAD)] is a particularly intriguing phenomenon. This study delves into the effectiveness of [fluoxetine] and [bright light therapy] as treatments for SAD. Employing a [randomized, parallel design], researchers compared the two approaches in a group of [40 patients] diagnosed with SAD. The researchers found that [both treatments produced a good antidepressant effect and were well tolerated], with [bright light] showing a possible edge in terms of [remission rate].

Shining Light on Seasonal Blues: A Battle Between Fluoxetine and Bright Light

The results suggest that both [fluoxetine] and [bright light therapy] can be effective in treating SAD, with [bright light therapy] potentially having a greater impact on [remission]. This study highlights the importance of individualized treatment approaches for SAD, as both therapies have distinct advantages.

Shining Light on Seasonal Blues: A Battle Between Fluoxetine and Bright Light

For those suffering from SAD, these findings provide a ray of hope. It's encouraging to know that both [fluoxetine] and [bright light therapy] can offer relief. Remember, the best approach for you depends on individual factors, and consulting a qualified healthcare professional is essential to determine the optimal treatment plan.

Dr. Camel's Conclusion

This study, like the vast desert, offers a rich landscape of insights into the treatment of SAD. While both fluoxetine and bright light therapy show promise, the researchers suggest that further exploration with a larger sample size is needed. This underscores the importance of continued research in [mental health], as we journey to find the oasis of relief for those struggling with this seasonal condition. Just like a camel navigating the desert, finding the right treatment path for SAD can be challenging, but with careful consideration and a bit of resilience, we can reach our destination.

Date :
  1. Date Completed 1998-11-02
  2. Date Revised 2022-12-07
Further Info :

Pubmed ID

9723147

DOI: Digital Object Identifier

10.1017/s0033291798006813

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.